Cargando…
Aspirin Inhibits the Inflammatory Response of Protease-Activated Receptor 1 in Pregnancy Neutrophils: Implications for Treating Women with Preeclampsia
Neutrophils expressing cyclooxygenase-2 (COX-2) extensively infiltrate maternal blood vessels in preeclampsia, associated with vascular inflammation. Because pregnancy neutrophils also express protease-activated receptor 1 (PAR-1, F2R thrombin receptor), which they do not in non-pregnant subjects, t...
Autores principales: | Walsh, Scott W., Al Dulaimi, Marwah, Strauss, Jerome F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654155/ https://www.ncbi.nlm.nih.gov/pubmed/36362006 http://dx.doi.org/10.3390/ijms232113218 |
Ejemplares similares
-
Gene Expression of Pregnancy Neutrophils Differs for Protease versus Lipopolysaccharide Stimulation
por: Walsh, Scott W., et al.
Publicado: (2022) -
Patterns of Maternal Neutrophil Gene Expression at 30 Weeks of Gestation, but Not DNA Methylation, Distinguish Mild from Severe Preeclampsia
por: Walsh, Scott W., et al.
Publicado: (2021) -
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
por: Walsh, Scott W., et al.
Publicado: (2021) -
Aspirin for Prevention of Preeclampsia in Lupus Pregnancy
por: Schramm, Amelie M., et al.
Publicado: (2014) -
Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy
por: Stephenson, Daniel J., et al.
Publicado: (2023)